Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer
Colorectal cancer (CRC) is the second most common cause of cancer death, leading to almost 1 million deaths per year. Despite constant progress in surgical and therapeutic protocols, the 5-year survival rate of advanced CRC patients remains extremely poor. Colorectal Cancer Stem Cells (CRC-CSCs) are...
Main Authors: | Donatella Lucchetti, Francesca Luongo, Filomena Colella, Enrico Gurreri, Giulia Artemi, Claudia Desiderio, Stefano Serra, Felice Giuliante, Ruggero De Maria, Alessandro Sgambato, Alberto Vitali, Micol Eleonora Fiori |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223004675 |
Similar Items
-
CD147 Promotes Cell Small Extracellular Vesicles Release during Colon Cancer Stem Cells Differentiation and Triggers Cellular Changes in Recipient Cells
by: Donatella Lucchetti, et al.
Published: (2020-01-01) -
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
by: Donatella Lucchetti, et al.
Published: (2021-11-01) -
Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
by: Donatella Lucchetti, et al.
Published: (2020-01-01) -
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
by: Francesca Luongo, et al.
Published: (2019-07-01) -
Terminal Cyclohexane-Type Meroterpenoids from the Fruiting Bodies of Ganoderma cochlear
by: Fu-Ying Qin, et al.
Published: (2021-12-01)